Sers for Point of Care and Clinical Applications
SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection
Book sections
Crawford, B; Wang, HN; Vo-Dinh, T
January 1, 2022
This chapter presents an overview of SERS molecular sentinels for cancer detection.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Crawford, B., Wang, H. N., & Vo-Dinh, T. (2022). SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection. In Sers for Point of Care and Clinical Applications (pp. 135–167). https://doi.org/10.1016/B978-0-12-820548-8.00005-9
Crawford, B., H. N. Wang, and T. Vo-Dinh. “SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection.” In Sers for Point of Care and Clinical Applications, 135–67, 2022. https://doi.org/10.1016/B978-0-12-820548-8.00005-9.
Crawford B, Wang HN, Vo-Dinh T. SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection. In: Sers for Point of Care and Clinical Applications. 2022. p. 135–67.
Crawford, B., et al. “SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection.” Sers for Point of Care and Clinical Applications, 2022, pp. 135–67. Scopus, doi:10.1016/B978-0-12-820548-8.00005-9.
Crawford B, Wang HN, Vo-Dinh T. SERS-based molecular sentinel nanoprobes for nucleic acid biomarker detection. Sers for Point of Care and Clinical Applications. 2022. p. 135–167.